Ticker Symbol: IBIO
iBio Inc
$0.69 - 20-12-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Currency:
USD
Asset
Type: Common Stock
CIK:0001420720
Company Profile
iBio is a global leader in plant-based biologics manufacturing. Its FastPharming® System combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing proprietary products on the FastPharming Platform, which include biopharmaceuticals for the treatment of fibrotic and infectious diseases, amongst others. The Company's subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services, including Glycaneering™ Development Services for advanced recombinant protein design.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.ibioinc.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.36
Change:
$0.00
(
2.73%)
Days Range: $0.33 - $0.38
Beta: 1.14
52wk. High: $2.60
52wk. Low: $0.26
Ytd. Change -16.12%
50 Day Moving Average: $0.31
200 Day Moving Average: $0.63
Shares Outstanding: 27586499
Valuation
Market Cap: 994.8M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A